1267669

Glaukos Corporation — FEI 3012341472

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 22, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Clemente, CA (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures